Cartesian Therapeutics Inc. (RNAC) short volume · P/E 2.1, rev $38.9M
Cartesian Therapeutics Inc. FINRA short-volume cache. Latest 2026-08-18.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-08-18 | 36,943 | 64,858 | 57.0% |
| 2026-08-17 | 21,171 | 33,946 | 62.4% |
| 2026-08-14 | 19,503 | 27,304 | 71.4% |
| 2026-08-13 | 14,942 | 19,729 | 75.7% |
| 2026-08-12 | 18,103 | 26,053 | 69.5% |
| 2026-08-11 | 11,087 | 27,073 | 41.0% |
| 2026-08-10 | 11,701 | 20,975 | 55.8% |
| 2026-08-07 | 23,604 | 41,055 | 57.5% |
| 2026-08-06 | 24,921 | 48,892 | 51.0% |
| 2026-08-05 | 26,247 | 37,660 | 69.7% |
FAQ
What is RNAC P/E and revenue?
Cartesian Therapeutics Inc. (RNAC) P/E 2.1, rev $38.9M.
What is RNAC short volume?
Cartesian Therapeutics Inc. last cached short volume is 57.0% of total volume on 2026-08-18.
Not investment advice. Cached rows, not a live tape.